期刊文献+

急性髓系白血病四色流式细胞术免疫学分型特点分析 被引量:1

Characteristic analysis of actue myeloid leukemia immunophenotyping by using four-color flow cytometry
下载PDF
导出
摘要 目的探讨急性髓系白血病(AML)的免疫表型特征与意义。方法采用流式细胞术四色免疫荧光直接标记技术与CD45/SSC设门分析技术,检测105例AML患者,根据抗体积分系统进行分型。结果 105例AML病例中免疫表型分析显示,各种抗原的阳性表达依次为CD13(97.1%)、CD33(90.5%)、MPO(79.0%);干/祖细胞分化抗原表达依次为CD117(77.1%)、HLA-DR(72.4%)、CD34(54.3%)。其中跨系表达:淋系抗原表达阳性的AML(36.4%),主要表达CD19、CD7、CD2、CD10、CD8;跨阶段表达(36.4%):以CD34+CD11b+和CD34+CD11c+共表达2种异常最多见。缺失表达(27.3%):以CD13、CD33及HLA-DR等抗原缺失表达易见。结论流式细胞术四色免疫荧光直接标记法对某些特殊类型的白血病有重要的意义,有助于指导临床诊断、治疗及判断预后。 Objective To study the characteristic of immunophenotype of actue myeloid leukemia(AML) and its significance.Methods Four-color direct immunofluorescence staining methods of flow cytometry and CD45/SSC gating analytical technique were taken for detection of 105 cases of AML,and antibody integration system were used for immunophenotype.Results Immunophenotyping of 105 cases of AML showed that all antigens expressed positive were CD13(97.1%),CD33(90.5%),MPO(79.0%)by turns and stem/progenitor cells differentiation antigen expressed were CD117(77.1%),human leukocyte antigen locus DR(HLA-DR)(72.4%),CD34(54.3%) by turns.Patients with AML accompanied positive lymphocyte antigen expressed CD19,CD7,CD2,CD10,CD8.CD34+CD11b+ and CD34+CD11c+ were the two most common expressed abnormality of bestride the stage.CD13,CD33 and HLA-DR were the most visible in the antigen deletion expressed.Conclusion Four-color direct immunofluorescence staining methods of flow cytometry has important significance for special types of AML,and it can help to guide clinical diagnosis,treatment and prognosis.
出处 《新乡医学院学报》 CAS 2011年第3期323-325,共3页 Journal of Xinxiang Medical University
关键词 急性髓系白血病 免疫学分型 流式细胞术 淋巴系分化抗原 acute myeloid leukemia immunophenotype flow cytometry
  • 相关文献

参考文献7

二级参考文献57

  • 1宋建新,苏敏,张芹,方蒡,甸自金,欧阳红梅,陈斌,台虹.282例急性白血病流式细胞术免疫分型的特点分析[J].现代检验医学杂志,2005,20(1):35-38. 被引量:11
  • 2时昊,张志瑢,肖爱琴,朱锋,张日.c-kit受体与其他髓系膜抗原标志物对急性非淋巴细胞白血病诊断价值的比较[J].中华内科杂志,2005,44(5):384-385. 被引量:12
  • 3Ichinohasama R, DeCoteau JF, MyersJ, et al. Three colorflowcytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes[ J]. Leukemia, 1997, 11:1891.
  • 4Stelzer G T, Shuh K E, Loken M R. CD45 gating for routine flow cytomettic analysis of hunmn bone marrow specimens[J]. Ann NY Acad Sci, 1993,77:265.
  • 5Weir EG, Borowitz MJ. Floweytometry in the diagnosis of acute leukemia [J]. Semin Hematol,2001,38:124.
  • 6Huh Yo, Ibrahim S. Imnamophenotypes in adult acute lymphocytic leukemia. Rde of flowcytometry in diagnosis and monitoring of disease [J]. Hematol Oncol Clin North Am,2000,14:1251.
  • 7Bene M C, Castoldi G, Knappe W, et al. Proposal for the classification of acute leukemias. European group for the immunological characterization of leukemias[J]. Leukemia, 1995, 9: 1783.
  • 8Legrand O, Perror J Y, Simonin G, et al. Adult biphenotypic acute leukemia: an entity with poor progrosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression [J]. British Journal of Haematology, 1998, 100: 147-155.
  • 9Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia[J]. Haematologic, 1997, 82: 64-66.
  • 10Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukemia [J]. Leukemia, 1996, 10: 1283- 1287.

共引文献50

同被引文献12

  • 1Lund B,Asberg A,Heyman M. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia[J].Pediatric Blood & Cancer,2011,(04):551-559.
  • 2Kawakami C,Inoue A,Takitani K. Successful treatment of acute monocytic leukemia with intracranial hemorrhage as the first manifestation[J].Pediatrics International,2010,(04):e218-e220.
  • 3殷慧君.小儿急性白血病的化学治疗[M]北京:科学出版社,199655.
  • 4Kim H,Lee JH,Choi SJ. Risk score model for fatal intracranial hemorrhage in acute leukemia[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2006,(05):770-776.
  • 5Yanada M,Matsushita T,Asou N. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia:incidence,risk factors,and influence on outcome[J].European Journal of Haematology,2007,(03):213-219.doi:10.1111/j.1600-0609.2006.00803.x.
  • 6Chen CY,Tai CH,Tsay W. Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia[J].Annals of Oncology,2009,(06):1100-1104.doi:10.1093/annonc/mdn755.
  • 7Astwood E,Vora A. Personal practice:how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia[J].British Journal of Haematology,2011,(05):505-511.
  • 8Dayyani F,Mougalian SS,Naqvi K. Prediction model for mortality after intracranial hemorrhage in patients with leukemia[J].American Journal of Hematology,2011,(07):546-549.
  • 9Rubnitz JE,Gibson B,Smith FO. Acute myeloid leukemia[J].Hematology/Oncology Clinics of North America,2010,(01):35-63.
  • 10Molgaard-Hansen L,Mottonen M,Glosli H. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries:1984-2003[J].British Journal of Haematology,2010,(05):447-459.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部